Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer

There is no fulltext present in this item.

Title:	Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
Author(s):	Marchi, T. De; Timmermans, A.M.; Smid, M.; Look, M.P.; Stingl, C.; Opdam, M.; Linn, S.C.; Sweep, C.G.J. ; Span, P.N. ; Kliffen, M.; Deurzen, C.H. van; Luider, T.M.; Foekens, J.A.; Martens, J.W.; Umar, A.; Albers, E.M.
Publication year:	2016
Source:	Oncotarget, vol. 7, iss. 3, (2016), pp. 3098-3110
ISSN:	1949-2553
DOI:	https://doi.org/10.18632/oncotarget.6521
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/171416
Display more details
Subject:	Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences
Organization:	Laboratory Medicine Radiation Oncology
Journal title:	Oncotarget
Volume:	vol. 7
Issue:	iss. 3
Page start:	p. 3098
Page end:	p. 3110